![Protagenic Therapeutics Inc](/common/images/company/N_PTIX.png)
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0493 | -6.57333333333 | 0.75 | 0.798 | 0.7007 | 3232 | 0.71659499 | CS |
4 | -0.1993 | -22.1444444444 | 0.9 | 0.935 | 0.7007 | 6803 | 0.76978666 | CS |
12 | -0.6393 | -47.7089552239 | 1.34 | 1.87 | 0.7007 | 13524 | 1.3318442 | CS |
26 | -0.189401 | -21.2785964739 | 0.890101 | 1.87 | 0.7007 | 12130 | 1.32757961 | CS |
52 | -1.4193 | -66.9481132075 | 2.12 | 2.22 | 0.6797 | 11191 | 1.24448801 | CS |
156 | -7.7793 | -91.7370283019 | 8.48 | 9.4 | 0.6797 | 77124 | 6.33250288 | CS |
260 | -10.2993 | -93.63 | 11 | 19.56 | 0.6797 | 411882 | 11.24206835 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.